Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

My Top 2 Stocks: Thompson Creek Metals Company Inc (USA) (TC) and Bank of America Corp (BAC)

Page 1 of 2

For those of you who’ve been following my One Person’s Trash Is Another Person’s Treasure portfolio, it shouldn’t come as a surprise to anyone that I love beaten-down, out-of-favor, contrarian, and value plays. One of my primary investing philosophies is to follow the Warren Buffett adage to buy when others are fearful and sell when others are greedy. With that being said, let’s delve into two of my top holdings — Thompson Creek Metals Company Inc (USA) (NYSE:TC) and Bank of America Corp (NYSE:BAC) — and I’ll share with you what led me in their direction, as well as where I feel they may head next.

However, before we do that, I should preface this by saying that we at the Fool have strict rules about analyzing companies with market caps below $200 million and volume levels below 250,000 shares per day (you can see the trading requirements we contributors follow by reading the Fool’s disclosure policy). As such, I’ll be leaving the discussion of my largest holding off the table since it doesn’t meet these requirements and discussing Thompson Creek Metals Company Inc (USA) (NYSE:TC) and Bank of America Corp (NYSE:BAC), my No. 2 and No. 3 holdings in terms of dollar value, instead.

Bank of America Corp (NYSE:BAC)A mulligan on Milligan
My initial attraction to Thompson Creek Metals Company Inc (USA) (NYSE:TC) began in 2010 more as a fascination with the application of molybdenum than anything else. That perception changed rapidly after Thompson Creek Metals Company Inc (USA) (NYSE:TC) announced the acquisition of Terrane Metals in July 2010, acquiring the Mt. Milligan copper and gold mine in British Columbia.

On paper, Mt. Milligan is everything that Thompson Creek shareholders had dreamed of and more. The mine was going to diversify Thompson Creek away from just being a molybdenum producer, and it boasted huge promises of profits with 2.1 billion pounds of copper and 6 million ounces of gold to be divvied out over its 22-year lifespan.

Those dreams have been squashed over the past year, however, as molybdenum costs have fallen and Mt. Milligan’s build-out costs have soared. Thompson Creek’s management had hoped to fund the mine’s construction through operating cash flow, but was instead forced to shut down its moly operations in order to conserve cash and sell off its stockpile while also orchestrating two separate gold royalty interest deals with Royal Gold, Inc USA) (NASDAQ:RGLD) , netting it precious upfront capital in return for giving up 52% of its gold interests to Royal Gold.

The allure of Thompson Creek Metals Company Inc (USA) (NYSE:TC) is purely based on the impending success of Mt. Milligan, which is set to open in the fourth-quarter of this year. While costly, the build-out has remained on track, and I wouldn’t be shocked if Thompson Creek turned in $1 in EPS in 2014, placing it at a forward P/E of around three for those of you who hate math!

Furthermore, growth in China is working perfectly in Thompson Creek’s favor. Just last week Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX)‘s senior vice president of marketing and sales announced his company’s intention to possibly double copper sales to China from 500,000 metric tons to 1 million metric tons, according to a report from Bloomberg. With China passing infrastructure bills aimed at getting its growth back on track, copper usage is expected to remain strong, right in time for Mt. Milligan to come on line.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!